US Patent Issued to MEDICOVESTOR on March 4 for "Nucleic acids, vectors, and cells that encode antibodies and other proteins that bind folate receptor alpha" (Delaware Inventor)

ALEXANDRIA, Va., March 5 -- United States Patent no. 12,240,900, issued on March 4, was assigned to MEDICOVESTOR INC. (Wilmington, Del.).

"Nucleic acids, vectors, and cells that encode antibodies and other proteins that bind folate receptor alpha" was invented by Seah Lim (Wilmington, Del.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure describes nucleic acids that encode proteins that specifically bind human folate receptor alpha (FRalpha) with high affinity. These proteins include a recombinant human anti-FRalpha IgG1 that is suitable for use as a therapeutic antibody to treat cancers that express FRalpha. Other FRalpha-binding proteins are also described including antibody fragments, antibo...